Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
AffiliationBeaumont Hospital, Department of Gastroenterology, Beaumont Road, Dublin, D8, Ireland. firstname.lastname@example.org
Anti-Inflammatory Agents, Non-Steroidal
Clinical Trials as Topic
Disease Models, Animal
Drug Delivery Systems
MetadataShow full item record
CitationCyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age? 2009, 13 (2):209-18 Expert Opin. Ther. Targets
JournalExpert opinion on therapeutic targets
AbstractCOX-2 is upregulated at an early stage in colorectal carcinogenesis and generates prostaglandins, which promote cancer cell proliferation, impair apoptosis and enhance angiogenesis, promoting tumour growth and metastasis. There are ample data from animal models and human studies to demonstrate enhanced tumour progression associated with COX-2 activity in cancer cells. Conversely, NSAIDs including aspirin inhibit COX-2 and, therefore, have anti-neoplastic properties. There has been sustained interest in COX-2 as a chemopreventive target in colorectal cancer (CRC) and although both aspirin and COX-2 selective NSAIDs have demonstrated efficacy, adverse effects have limited their widespread adoption. In particular, evidence of the cardiovascular effects of COX-2 selective inhibitors has led to questioning of the suitability of COX-2 as a target for chemoprevention. This review examines the basis for targeting COX-2 in CRC chemoprevention, evaluates the efficacy and safety of the approach and examines future strategies in this area.
- Chemoprevention of colorectal cancer: ready for routine use?
- Authors: Arber N, Levin B
- Issue date: 2005
- Use of NSAIDs for the chemoprevention of colorectal cancer.
- Authors: Herendeen JM, Lindley C
- Issue date: 2003 Nov
- Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.
- Authors: Chu AJ, Chou TH, Chen BD
- Issue date: 2004 Sep 1
- Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
- Authors: Hahn E, Kraus S, Arber N
- Issue date: 2010
- Cyclooxygenase as a target for colorectal cancer chemoprevention.
- Authors: Moreira L, Castells A
- Issue date: 2011 Dec